secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2023-08-09T23:59:59+00:00
Accession:  0001628280-23-028406
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth Q2 net sales $117.5M (+13% YoY); net income $3.4M; reaffirms FY guidance
--------------------------------------------------------------------------------

- Net sales $117.5M (+13% YoY); net income $3.4M; adjusted EBITDA margin 15.1%.
- Reaffirms 2023 net sales and 2025 guidance; refines 2023 adj. EBITDA margin to 18%-19%.
- Consumables net sales +34% YoY; delivery systems +1% (or +30% ex trade-ups).
- APAC net sales +143% YoY (China +265%); partner LaserAway for Syndeo at 125+ locations.
- FDA clearance for SkinStylus for facial acne scarring; AWS collaboration for generative AI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828023028406/0001628280-23-028406-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828023028406/skin-20230809.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-028406

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer